Healthcare provider profile · identity verified

Michael Graham Miles, MD

Internal Medicine · GLENS FALLS, NY · NPI 1649412982

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	445	136
Lisinopril	Lisinopril	356	98
Omeprazole	Omeprazole	305	90
Amlodipine Besylate	Amlodipine Besylate	221	70
Gabapentin	Gabapentin	196	49
Metoprolol Succinate	Metoprolol Succinate	187	58
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	179	30
Albuterol Sulfate Hfa	Albuterol Sulfate	167	51
Levothyroxine Sodium	Levothyroxine Sodium	167	50
Losartan Potassium	Losartan Potassium	154	43
Simvastatin	Simvastatin	138	40
Tamsulosin Hcl	Tamsulosin Hcl	132	42
Metformin Hcl	Metformin Hcl	122	31
Eliquis	Apixaban	118	31
Hydrochlorothiazide	Hydrochlorothiazide	116	36
Rosuvastatin Calcium	Rosuvastatin Calcium	110	36
Furosemide	Furosemide	102	39
Metformin Hcl Er	Metformin Hcl	96	28
Oxycodone Hcl	Oxycodone Hcl	96	29
Metoprolol Tartrate	Metoprolol Tartrate	73	20
Allopurinol	Allopurinol	70	19
Fluoxetine Hcl	Fluoxetine Hcl	69	12
Duloxetine Hcl	Duloxetine Hcl	68	20
Fluticasone Propionate	Fluticasone Propionate	67	27
Pantoprazole Sodium	Pantoprazole Sodium	67	19
Famotidine	Famotidine	66	22
Prednisone	Prednisone	66	42
Clopidogrel	Clopidogrel Bisulfate	63	18
Potassium Chloride	Potassium Chloride	60	17
Sertraline Hcl	Sertraline Hcl	60	17
Alprazolam	Alprazolam	59	21
Ozempic	Semaglutide	59	16
Lorazepam	Lorazepam	58	15
Clonazepam	Clonazepam	55	suppressed
Trazodone Hcl	Trazodone Hcl	50	16
Alendronate Sodium	Alendronate Sodium	47	16
Enalapril Maleate	Enalapril Maleate	47	12
Ezetimibe	Ezetimibe	45	suppressed
Paroxetine Hcl	Paroxetine Hcl	43	suppressed
Jardiance	Empagliflozin	42	14
Baclofen	Baclofen	39	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	13
Diazepam	Diazepam	37	suppressed
Hydralazine Hcl	Hydralazine Hcl	37	suppressed
Tramadol Hcl	Tramadol Hcl	37	15
Carvedilol	Carvedilol	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	36	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	11
Mirtazapine	Mirtazapine	36	15
Carbamazepine Er	Carbamazepine	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	34	15
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Naproxen	Naproxen	33	suppressed
Pregabalin	Pregabalin	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Donepezil Hcl	Donepezil Hcl	31	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Finasteride	Finasteride	30	13
Linzess	Linaclotide	30	suppressed
Montelukast Sodium	Montelukast Sodium	30	11
Morphine Sulfate Er	Morphine Sulfate	30	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	28	12
Bydureon Bcise	Exenatide Microspheres	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	11
Nortriptyline Hcl	Nortriptyline Hcl	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Glipizide	Glipizide	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Azelastine Hcl	Azelastine Hcl	19	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Indomethacin	Indomethacin	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Colchicine	Colchicine	18	suppressed
Lacosamide	Lacosamide	18	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Atenolol	Atenolol	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Ramipril	Ramipril	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Epinephrine	Epinephrine	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Fycompa	Perampanel	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	11	11
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error